𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Novel Synthetic Method of Phosphonamidate Peptides and Its Application in Peptide Sequencing via Multistage Mass Spectrometry.

✍ Scribed by Huiwang Ai; Hua Fu; Yufen Zhao

Publisher
John Wiley and Sons
Year
2004
Weight
49 KB
Volume
35
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection and localisation of disulphide
Detection and localisation of disulphide bonds in a synthetic peptide reproducing the sequence 1–30 of Par j 1.0101 by electrospray ionisation mass spectrometry
✍ Vincenzo Cunsolo; Salvatore Foti; Rosaria Saletti; Leopoldo Ceraulo; Vita Di Ste 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Detection and localisation of disulphide bonds in a synthetic peptide reproducing the sequence 1-30 of Par j 1.0101 by electrospray ionisation mass spectrometry The structural characterisation of a synthetic peptide reproducing the sequence 1-30 of Par j 1.0101, a major allergenic protein prese

Development and validation of a liquid c
Development and validation of a liquid chromatography–tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples
✍ Sebastian Dresen; Stefan Kneisel; Wolfgang Weinmann; Ralf Zimmermann; Volker Auw 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

## Abstract After the discovery of synthetic cannabimimetic substances in ‘Spice’‐like herbal mixtures marketed as ‘incense’ or ‘plant fertilizer’ the active compounds have been declared as controlled substances in several European countries. As expected, a monitoring of new herbal mixtures which c

Development and validation of a high-per
Development and validation of a high-performance liquid chromatography–tandem mass spectrometry method for the determination of the novel proteasome inhibitor CEP-18770 in human plasma and its application in a clinical pharmacokinetic study
✍ Federica Sala; Elena Marangon; Renzo Bagnati; Valeria Livi; Roberta Cereda; Maur 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

## Abstract CEP‐18770, [(1__R__)‐1‐{[(2__S__,3__R__)‐3‐hydroxy‐2‐{[(6‐phenyl‐2‐pyridinyl)carbonyl]amino}butanoyl]amino}‐3‐methylbutyl]boronic acid, is a novel proteasome inhibitor, now under early clinical evaluation as an anticancer agent. To investigate its clinical pharmacokinetics, a high‐perfo

Development and validation of a high-per
Development and validation of a high-performance liquid chromatography–tandem mass spectrometry method for the determination of the novel inhibitor of angiogenesis E-3810 in human plasma and its application in a clinical pharmacokinetic study
✍ Federica Sala; Renzo Bagnati; Valeria Livi; Roberta Cereda; Maurizio D'Incalci; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

E‐3810, 6‐[[7‐[(1‐aminocyclopropyl)methoxy]‐6‐methoxy‐4‐quinolyl]oxy]‐__N__‐methyl‐naphthalene‐1‐carboxamide, is a novel, potent, dual inhibitor of vascular endothelial growth factor and fibroblast growth factor receptors with antiangiogenic properties, now under early clinical evaluation as an anti